We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App





Bio-Rad Exhibits Range of Solutions for Maximizing Lab Efficiency at AACC

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: Visitors to the company’s booth at AACC 2022 saw a range of solutions that support labs by maximizing efficiency (Photo courtesy of Bio-Rad)
Image: Visitors to the company’s booth at AACC 2022 saw a range of solutions that support labs by maximizing efficiency (Photo courtesy of Bio-Rad)

At the 2022 AACC Clinical Lab Expo, Bio-Rad Laboratories (Hercules, CA, USA) is presenting its range of solutions that support labs by maximizing efficiency through streamlining workflows, consolidating platforms, improving turnaround time and gaining confidence in results.

Bio-Rad is exhibiting its quality control solutions that help streamline workflows, reduce errors, maintain compliance, and facilitate accreditation—improving efficiency and saving money. These solutions included its InteliQ Load-and-Go Controls that can transform QC workflow with load-and-go-efficiency. InteliQ quality controls, a smarter way to manage QC, help automate workflow - reducing turnaround time, limiting manual errors, and increasing overall efficiency. Bio-Rad will also present its Unity QC Data Management Solutions that help achieve greater efficiency while reducing costs. In addition to identifying trends and making corrections before results are compromised, connectivity to the world’s largest community of QC users brings the confidence and reliability to stand behind the results. Also on display will be the company’s comprehensive line of molecular quality controls, standards, and data management solutions that streamline workflow and set a new standard in molecular lab performance.

Visitors at Bio-Rad’s AACC 2022 booth can experience its D-100 hemoglobin testing system, a fully automated, best-in-class HbA1c analyzer featuring a highly evolved combination of hardware, software and chemistry for high-volume labs, and the BioPlex 2200 System, which consolidates autoimmune, infectious disease, and vitamin D testing all on one fully automated, track line compatible, random-access platform. Also on display at the event will be IH-500, the latest addition to the Bio-Rad IH-Complete family of immunohematology testing systems that delivers an easy-to-use, fully automated system with random access and minimal user intervention. In addition, Bio-Rad is showcasing the IH-Reader 24, a combination centrifuge and reader for convenient and intelligent processing of manually pipetted IH-Gel Cards; the IH-1000 fully automated, walk-away system for ID-Cards with high-throughput, continuous sample and reagent loading; and the IH-Centrifuge L and IH-Incubator L, small but powerful members of the IH-Complete family that allow labs of all sizes to standardize gel and tube applications.
 

Related Links:
Bio-Rad Laboratories 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Unstirred Waterbath
HumAqua 5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.